Aull & Monroe Investment Management Corp Abbott Laboratories Transaction History

Aull & Monroe Investment Management Corp

$217 Million
Q1 2024

A detailed history of Aull & Monroe Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 19,118 shares of ABT stock, worth $1.97 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

19,118

Previous 19,551 2.21%

Holding current value

$1.97 Million

Previous $2.15 Million 0.98%

% of portfolio

1.0%

Previous 1.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $47,422 - $52,375	-433 Reduced 2.21%	19,118 $2.17 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $49,875 - $61,051	-553 Reduced 2.75%	19,551 $2.15 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $44,994 - $53,986	-471 Reduced 2.29%	20,104 $1.95 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $91,048 - $107,169	-940 Reduced 4.37%	20,575 $2.08 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $52,663 - $61,782	-554 Reduced 2.51%	21,515 $2.36 Million

Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $10,819 - $13,077	-106 Reduced 0.48%	22,069 $2.4 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 0.89%	22,175 $2.63 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $24,723 - $30,272	-214 Reduced 0.95%	22,375 $3.15 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $1,166 - $1,290	-10 Reduced 0.04%	22,589 $2.67 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 0.88%	22,599 $2.71 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $6,825 - $7,437	-65 Reduced 0.28%	22,799 $2.5 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 0.44%	22,864 $2.49 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $155,207 - $198,646	-2,027 Reduced 8.11%	22,964 $2.1 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $62,808 - $69,920	-800 Reduced 3.1%	24,991 $2.17 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $101,481 - $110,037	-1,240 Reduced 4.59%	25,791 $2.16 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $21,864 - $25,500	-300 Reduced 1.1%	27,031 $2.27 Million
Q1 2019 Apr 18, 2019	SELL	$66.22 - $80.06 $79,464 - $96,072	-1,200 Reduced 4.21%	27,331 $2.19 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $127,842 - $144,826	-1,950 Reduced 6.4%	28,531 $2.06 Million
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $24,324 - $29,344	-400 Reduced 1.3%	30,481 $2.24 Million
Q2 2018 Jul 24, 2018	SELL	$57.57 - $63.54 $25,906 - $28,593	-450 Reduced 1.44%	30,881 $1.88 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $16,881 - $19,086	-300 Reduced 0.95%	31,331 $1.88 Million
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $31,134 - $33,332	-580 Reduced 1.8%	31,631 $1.81 Million
Q3 2017 Oct 26, 2017	SELL	$48.06 - $53.64 $9,612 - $10,728	-200 Reduced 0.62%	32,211 $1.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	32,411	32,411 $1.58 Million

Others Institutions Holding ABT

# of Institutions

3,132

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $180B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Abbott Laboratories Transaction History